Events

Date: April 28, 2022
Time: 4:45 PM - 8:30 PM
Location: LabCentral Lobby

Boehringer Ingleheim is excited to welcome you to the BI Innovation Prize, BI Academy & Spring Networking Reception event where together we can celebrate innovation with our 2022 Boston Innovation Prize and discuss a key topic of interest in our Boehringer Ingelheim Academy session. We look forward to joining you for an evening of celebration, discussion, and networking!

Register here!

In our first ‘in person’ BI Academy session since early 2020, we will be reflecting on the experiences of the last couple of years and how flexibility, agility and resilience have enabled us to adopt new ways of working and continue to support breakthrough science and the innovators that are making that happen. As we emerge into our ‘New Normal’ we look forward to discussing how these unprecedented circumstances have shaped our partnering experiences.

Moderator: Scott DeWire, US Head of BD&L, Boehringer Ingelheim

Panelists:

Fei Shen, US Head of Venture Fund, Boehringer Ingelheim
Junjun Gao, Research Beyond Borders , Boehringer Ingelheim
Jonathan Violin, CEO and Founder, Viridian Therapeutics Inc
Priyanka Rhogati, Venture Partner, Longwood Fund

EVENING AGENDA

4:45 pm - 5:15pm: Arrival and Registration
5:15 pm - 6:00pm: Networking Reception
6:00 pm - 7:00pm: BI Academy Panel
7:00 pm - 7:15pm: Announce top 5 of Innovation Prize Finalists
7:15 pm - 8:00 pm: Pitch Presentations
8:00 pm - 8:15pm: Judging for Grand Prize
8:15 pm - 8:30 pm: Innovation Prize Award

All attendees of the Boehringer Ingelheim Innovation Prize event will be required to confirm proof of full vaccination with LabCentral Event Manager(s) and provide a day of, negative rapid COVID test, as both these documents will be reviewed when checking into the event. Rapid COVID tests will not be provided by LabCentral or Boehringer Ingelheim at the event, so all attendees must plan accordingly.